top of page
Lab Experiment

Sponsors

At Sydney Clinical Trials our expert team is tailored to the needs of our global client base delivering exceptional service in Phase I-IV studies.

​

Our modern, custom-built facility, situated within Campbelltown Private Hospital provides ready access to state-of-the-art equipment and has a specialist focus on gastroenterology trials. We have access to inpatient beds, an on-site pharmacy and laboratory and private clinic rooms.

​

In residing outside of the public health system, Sydney Clinical Trials can respond to client needs in an agile and tailored manner, improving the speed of delivery of industry clinical trials.

Microscope

​Quality Assurance

Sydney Clinical Trials has a comprehensive risk-based quality management system and standard operating protocols (SOPs) to ensure delivery of services to the highest standards in alignment with:

01

​ISO19011

02

GCP, cGMP and cGLP

03

21 CFR 11

04

ISO14155

05

All relevant regulatory requirements (e.g. TGA, FDA)

Add paragraph text. Click “Edit Text” to update the font, size and more. To change and reuse text themes, go to Site Styles.

Why Sydney?

There are many advantages to completing your early phase trial in Sydney, Australia.  In Sydney, your trials will benefit from:

 

  • One of the fastest regulatory approval processes in the world for early phase trials. In Australia no IND is required to commence clinical trials. 

  • A generous research and development (R and D) tax incentive system where eligible companies can access a 43.5% cash refund for R and D activities (including clinical trial expenses) undertaken in Australia 

  • High-quality healthcare infrastructure

  • Clinical trial data generated in Australia (including first in human data) is recognised as high quality and in accordance with ICH GCP guidelines.  Australian clinical trial data has been used for regulatory filings with multiple regulatory bodies including the US FDA, PMDA, EMA and Health Canada regulatory bodies. 

  • Sydney has a population base of 5.4 million people and is known to have a high volunteer participation rate in clinical trials

  • Sydney is an ethnically diverse population which can enable trials within different ethnic groups

bottom of page